Mount Yale Investment Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,743
Closed -$222K 549
2024
Q2
$222K Buy
9,743
+2,368
+32% +$54.7K 0.02% 502
2024
Q1
$224K Buy
+7,375
New +$247K 0.02% 501
2023
Q4
Sell
-6,294
Closed -$276K 501
2023
Q3
$276K Buy
6,294
+102
+2% +$4.98K 0.03% 403
2023
Q2
$306K Buy
6,192
+393
+7% +$18.1K 0.03% 384
2023
Q1
$240K Buy
5,799
+120
+2% +$4.98K 0.03% 429
2022
Q4
$252K Sell
5,679
-99
-2% -$4.13K 0.03% 388
2022
Q3
$226K Sell
5,778
-49
-0.8% -$2.24K 0.03% 398
2022
Q2
$238K Buy
5,827
+1,277
+28% +$60.5K 0.03% 412
2022
Q1
$299K Buy
4,550
+243
+6% +$15.7K 0.03% 365
2021
Q4
$299K Sell
4,307
-161
-4% -$11.7K 0.03% 374
2021
Q3
$311K Buy
4,468
+68
+2% +$5.23K 0.04% 345
2021
Q2
$349K Sell
4,400
-62
-1% -$4.51K 0.04% 297
2021
Q1
$292K Sell
4,462
-787
-15% -$48.5K 0.04% 319
2020
Q4
$292K Buy
+5,249
New +$227K 0.04% 303

Other funds holding ATRC

Mount Yale Investment Advisors's ATRC Position: Q3 2024 in Review

Mount Yale Investment Advisors sold out of AtriCure (ATRC) in Q3 2024, closing a stake of 9,743 shares — an estimated $222K sold.

Mount Yale Investment Advisors first reported a position in ATRC in Q4 2020 and held it in 14 quarters. The position peaked at $349K in Q2 2021. 201 funds tracked by Wall St. Rank hold ATRC as of Q3 2024.

  • Mount Yale Investment Advisors reported no remaining AtriCure position as of Q3 2024 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 9,743 AtriCure shares in Q3 2024, an estimated $222K.
  • Mount Yale Investment Advisors first reported a position in AtriCure in Q4 2020 and held it in 14 quarters.
  • Mount Yale Investment Advisors's AtriCure position peaked at $349K in Q2 2021.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q3 2024.

Based on Mount Yale Investment Advisors's 13F filing for Q3 2024, filed 23 Oct 2024.